Hepatobiliary Cancer
14
5
7
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
7.1%
1 terminated out of 14 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (14)
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Senior Adult Hepatobiliary Prehab Study
Targeted Navigation in Hepatocellular Carcinoma (HCC)
Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for Cancer
Domvanalimab and Zimberelimab in Advanced Liver Cancers
Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis
Exercise Preconditioning with Cancer Surgeries
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
Sarcopenia and Physiology Assessments in Cancer Patients
NCI SBIR Contract for Patient Navigation Tool Prototype Development
Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program
Applying PET/MR in Oncology - a Prospective Project